{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:36:44Z","timestamp":1773697004070,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The diagnostic approach to hypopituitarism involves many disciplines. Clinical symptoms rarely are specific. Imaging techniques are helpful but cannot prove the specific functional defects. Therefore, the definitive diagnosis of pituitary insufficiency is largely based on laboratory tests. However, also laboratory methods come with inherent limitations, and it is essential for the clinician to know and recognize typical pitfalls. Most factors potentially impairing the quality of hormone measurements are introduced in the preanalytical phase, i.e. before the hormones are measured by the laboratory. For example, the timing of blood drawing with respect to circadian rhythm, stress, and medication can have an influence on hormone concentrations. During the actual analysis of the hormones, cross-reactions with molecules present in the sample presenting the same or similar epitopes than the intended analyte may affect immunoassays. Interference can also come from heterophilic or human anti-animal antibodies. Unexpected problems can also be due to popular nutritional supplements which interfere with the measurement procedures. An important example in this respect is the interference from biotin. It became only clinically visible when the use of this vitamin became popular among patients. The extreme serum concentrations reached when patients take it as a supplement can lead to incorrect measurements in immunoassays employing the biotin-streptavidin system. To some extent, hormone analyses using liquid chromatography mass spectrometry (LCMS) can overcome problems, although availability and cost-effectiveness of this method still imposes restrictions. In the post-analytical phase, appropriateness of reference intervals and cut-offs with respect to the specific analytical method used is of outmost importance. Furthermore, for interpretation, additional biological and pharmacological factors like BMI, age and concomitant diseases must be considered to avoid misinterpretation of the measured concentrations. It is important for the clinician and the laboratory to recognize when one or more laboratory values do not match the clinical picture. In an interdisciplinary approach, the search for the underlying cause should be initiated.<\/jats:p>","DOI":"10.1007\/s11154-024-09881-1","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T02:01:25Z","timestamp":1712973685000},"page":"457-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pitfalls in the lab assessment of hypopituitarism"],"prefix":"10.1007","volume":"25","author":[{"given":"Katharina","family":"Schilbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"key":"9881_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1258\/acb.2009.009222","volume":"47","author":"M Plebani","year":"2010","unstructured":"Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem. 2010;47:101\u201310.","journal-title":"Ann Clin Biochem"},{"key":"9881_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2265.1990.tb03758.x","volume":"32","author":"PM Horrocks","year":"1990","unstructured":"Horrocks PM, Jones AF, Ratcliffe WA, Holder G, White A, Holder R, et al. Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin Endocrinol (Oxf). 1990;32:127\u201334.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9881_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000180971","volume":"29","author":"GS Tannenbaum","year":"1988","unstructured":"Tannenbaum GS. Somatostatin as a physiological regulator of pulsatile growth hormone secretion. Horm Res. 1988;29:70\u20134.","journal-title":"Horm Res"},{"key":"9881_CR4","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1172\/JCI105893","volume":"47","author":"Y Takahashi","year":"1968","unstructured":"Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest. 1968;47:2079\u201390.","journal-title":"J Clin Invest"},{"key":"9881_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/07420529709040541","volume":"14","author":"L Weibel","year":"1997","unstructured":"Weibel L, Follenius M, Spiegel K, Gronfier C, Brandenberger G. Growth hormone secretion in night workers. Chronobiol Int. 1997;14:49\u201360.","journal-title":"Chronobiol Int"},{"key":"9881_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/07420528809078555","volume":"5","author":"J Salvador","year":"1988","unstructured":"Salvador J, Dieguez C, Scanlon MF. The circadian rhythms of thyrotrophin and prolactin secretion. Chronobiol Int. 1988;5:85\u201393.","journal-title":"Chronobiol Int"},{"key":"9881_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0165-1781(88)90008-X","volume":"23","author":"DA Sack","year":"1988","unstructured":"Sack DA, James SP, Rosenthal NE, Wehr TA. Deficient nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid-cycling bipolar illness. Psychiatry Res. 1988;23:179\u201391.","journal-title":"Psychiatry Res"},{"key":"9881_CR8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2007-2674","volume":"93","author":"W Russell","year":"2008","unstructured":"Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP, et al. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metabolism. 2008;93:2300\u20136.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"9881_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/j.1939-4640.1989.tb00120.x","volume":"10","author":"SR Plymate","year":"1989","unstructured":"Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl. 1989;10:366\u201371.","journal-title":"J Androl"},{"key":"9881_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.psyneuen.2008.10.026","volume":"34","author":"DH Hellhammer","year":"2009","unstructured":"Hellhammer DH, W\u00fcst S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163\u201371.","journal-title":"Psychoneuroendocrinology"},{"key":"9881_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0950-351X(87)80069-1","volume":"1","author":"G Delitala","year":"1987","unstructured":"Delitala G, Tomasi P, Virdis R. Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man. Baillieres Clin Endocrinol Metab. 1987;1:391\u2013414.","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"9881_CR12","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1210\/jc.2005-0354","volume":"90","author":"IE Widmer","year":"2005","unstructured":"Widmer IE, Puder JJ, K\u00f6nig C, Pargger H, Zerkowski HR, Girard J, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab. 2005;90:4579\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR13","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","volume":"36","author":"A-K Lennartsson","year":"2011","unstructured":"Lennartsson A-K, Jonsdottir IH. Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology. 2011;36:1530\u20139.","journal-title":"Psychoneuroendocrinology"},{"key":"9881_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0306-4530(94)00077-N","volume":"20","author":"WB Malarkey","year":"1995","unstructured":"Malarkey WB, Pearl DK, Demers LM, Kiecolt-Glaser JK, Glaser R. Influence of academic stress and season on 24-hour mean concentrations of ACTH, cortisol, and beta-endorphin. Psychoneuroendocrinology. 1995;20:499\u2013508.","journal-title":"Psychoneuroendocrinology"},{"key":"9881_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/bmj.1.6004.249","volume":"1","author":"H Kehlet","year":"1976","unstructured":"Kehlet H, Blichert-Toft M, Lindholm J, Rasmussen P. Short ACTH test in assessing hypothalamic-pituitary-adrenocortical function. Br Med J. 1976;1:249\u201351.","journal-title":"Br Med J"},{"key":"9881_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11154-020-09594-1","volume":"22","author":"NA Tritos","year":"2021","unstructured":"Tritos NA, Biller BMK. Current concepts of the diagnosis of adult growth hormone deficiency. Rev Endocr Metab Disord. 2021;22:109\u201316.","journal-title":"Rev Endocr Metab Disord"},{"key":"9881_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11102-021-01202-y","volume":"25","author":"MR Gadelha","year":"2022","unstructured":"Gadelha MR, Karavitaki N, Fudin J, Bettinger JJ, Raff H, Ben-Shlomo A. Opioids and pituitary function: expert opinion. Pituitary. 2022;25:52\u201363.","journal-title":"Pituitary"},{"key":"9881_CR18","doi-asserted-by":"crossref","unstructured":"Molitch ME. Medication-induced hyperprolactinemia. Mayo Clin Proc. 2005;80:1050\u20137.","DOI":"10.4065\/80.8.1050"},{"key":"9881_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","volume":"31","author":"V Birzniece","year":"2017","unstructured":"Birzniece V, Ho KKY. Sex steroids and the GH axis: implications for the management of hypopituitarism. Best Pract Res Clin Endocrinol Metab. 2017;31:59\u201369.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9881_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.beem.2016.11.002","volume":"30","author":"A Chinoy","year":"2016","unstructured":"Chinoy A, Murray PG. Diagnosis of growth hormone deficiency in the paediatric and transitional age. Best Pract Res Clin Endocrinol Metab. 2016;30:737\u201347.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9881_CR21","unstructured":"Czarnywojtek A, Zgorzalewicz-Stachowiak M, Czarnocka B, Sawicka-Gutaj N, Gut P, Krela-Kazmierczak I et al. Effect of lithium carbonate on the function of the thyroid gland: mechanism of action and clinical implications. J Physiol Pharmacol. 2020;71."},{"key":"9881_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3343\/alm.2022.42.1.3","volume":"42","author":"K Ghazal","year":"2022","unstructured":"Ghazal K, Brabant S, Prie D, Piketty M-L. Hormone immunoassay interference: a 2021 Update. Ann Lab Med. 2022;42:3\u201323.","journal-title":"Ann Lab Med"},{"key":"9881_CR23","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2012.188128","volume":"58","author":"J Manolopoulou","year":"2012","unstructured":"Manolopoulou J, Alami Y, Petersenn S, Schopohl J, Wu Z, Strasburger CJ, et al. Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin Chem. 2012;58:1446\u201356.","journal-title":"Clin Chem"},{"key":"9881_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0004563216674031","volume":"54","author":"S Mandic","year":"2017","unstructured":"Mandic S, Kratzsch J, Mandic D, Debeljak Z, Lukic I, Horvat V, et al. Falsely elevated serum oestradiol due to exemestane therapy. Ann Clin Biochem. 2017;54:402\u20135.","journal-title":"Ann Clin Biochem"},{"key":"9881_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1515\/cclm-2014-0067","volume":"52","author":"A Gessl","year":"2014","unstructured":"Gessl A, Blueml S, Bieglmayer C, Marculescu R. Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay. Clin Chem Lab Med. 2014;52:1589\u201394.","journal-title":"Clin Chem Lab Med"},{"key":"9881_CR26","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1515\/cclm-2019-1064","volume":"58","author":"N Verougstraete","year":"2020","unstructured":"Verougstraete N, Berth M, Vaneechoutte M, Delanghe J, Callewaert N. Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding? Clin Chem Lab Med. 2020;58:1673\u201380.","journal-title":"Clin Chem Lab Med"},{"key":"9881_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/clinchem\/44.3.440","volume":"44","author":"N Despr\u00e9s","year":"1998","unstructured":"Despr\u00e9s N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 1998;44:440\u201354.","journal-title":"Clin Chem"},{"key":"9881_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/js.2019-00027","volume":"3","author":"LW Greene","year":"2019","unstructured":"Greene LW, Geer EB, Page-Wilson G, Findling JW, Raff H. Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and Surgical Misadventure-A Case Series. J Endocr Soc. 2019;3:763\u201372.","journal-title":"J Endocr Soc"},{"key":"9881_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","volume":"27","author":"N Bolstad","year":"2013","unstructured":"Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013;27:647\u201361.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9881_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clinbiochem.2021.10.011","volume":"99","author":"\u00dc \u00d6nc\u00fcl","year":"2022","unstructured":"\u00d6nc\u00fcl \u00dc, Emino\u011flu FT, K\u00f6se E, Do\u011fan \u00d6, \u00d6zsu E, Aycan Z. Serum biotin interference: a troublemaker in hormone immunoassays. Clin Biochem. 2022;99:97\u2013102.","journal-title":"Clin Biochem"},{"key":"9881_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jcp-2022-208733","volume":"76","author":"S Brady","year":"2023","unstructured":"Brady S, Bates K, Oddy S, Jeon YL, Pichayayothin T, Tetteh R, et al. Prevalence of elevated serum concentrations of biotin in patients from South East England, Korea, Singapore and Thailand and risk of immunoassay interference. J Clin Pathol. 2023;76:637\u201341.","journal-title":"J Clin Pathol"},{"key":"9881_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1210\/js.2018-00069","volume":"2","author":"HM Stieglitz","year":"2018","unstructured":"Stieglitz HM, Korpi-Steiner N, Katzman B, Mersereau JE, Styner M. Suspected testosterone-producing Tumor in a patient taking biotin supplements. J Endocr Soc. 2018;2:563\u20139.","journal-title":"J Endocr Soc"},{"key":"9881_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jsbmb.2010.03.032","volume":"121","author":"HW Vesper","year":"2010","unstructured":"Vesper HW, Botelho JC. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol. 2010;121:513\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9881_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12020-013-0013-0","volume":"44","author":"H Raff","year":"2013","unstructured":"Raff H. Update on late-night salivary cortisol for the diagnosis of Cushing\u2019s syndrome: methodological considerations. Endocrine. 2013;44:346\u20139.","journal-title":"Endocrine"},{"issue":"Suppl 1","key":"9881_CR35","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1530\/EJE-08-0284","volume":"159","author":"M Bidlingmaier","year":"2008","unstructured":"Bidlingmaier M. Problems with GH assays and strategies toward standardization. Eur J Endocrinol. 2008;159(Suppl 1):S41\u201344.","journal-title":"Eur J Endocrinol"},{"key":"9881_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1515\/CCLM.2011.138","volume":"49","author":"C Carrozza","year":"2011","unstructured":"Carrozza C, Lapolla R, Canu G, Annunziata F, Torti E, Baroni S, et al. Human growth hormone (GH) immunoassay: standardization and clinical implications. Clin Chem Lab Med. 2011;49:851\u20133.","journal-title":"Clin Chem Lab Med"},{"key":"9881_CR37","doi-asserted-by":"publisher","first-page":"1266339","DOI":"10.3389\/fendo.2023.1266339","volume":"14","author":"DR Clemmons","year":"2023","unstructured":"Clemmons DR, Bidlingmaier M. Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly. Front Endocrinol (Lausanne). 2023;14:1266339.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9881_CR38","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1210\/jc.2017-00202","volume":"102","author":"M Mavromati","year":"2017","unstructured":"Mavromati M, Kuhn E, Agostini H, Brailly-Tabard S, Massart C, Piketty M-L, et al. Classification of patients with GH disorders May Vary according to the IGF-I assay. J Clin Endocrinol Metab. 2017;102:2844\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR39","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1017\/S095457942000111X","volume":"32","author":"EK Adam","year":"2020","unstructured":"Adam EK, Hittner EF, Thomas SE, Villaume SC, Nwafor EE. Racial discrimination and ethnic racial identity in adolescence as modulators of HPA axis activity. Dev Psychopathol. 2020;32:1669\u201384.","journal-title":"Dev Psychopathol"},{"key":"9881_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.009","volume":"93","author":"S Utge","year":"2018","unstructured":"Utge S, R\u00e4ikk\u00f6nen K, Kajantie E, Lipsanen J, Andersson S, Strandberg T, et al. Polygenic risk score of SERPINA6\/SERPINA1 associates with diurnal and stress-induced HPA axis activity in children. Psychoneuroendocrinology. 2018;93:1\u20137.","journal-title":"Psychoneuroendocrinology"},{"key":"9881_CR41","doi-asserted-by":"publisher","first-page":"bvac081","DOI":"10.1210\/jendso\/bvac081","volume":"6","author":"M Bidlingmaier","year":"2022","unstructured":"Bidlingmaier M, Valcour A, Schilbach K, Kuehnle T, Diederich S, Rogge T, et al. Differences in the distribution of IGF-I concentrations between European and US populations. J Endocr Soc. 2022;6:bvac081.","journal-title":"J Endocr Soc"},{"key":"9881_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2826.2008.01661.x","volume":"20","author":"DR Grattan","year":"2008","unstructured":"Grattan DR, Steyn FJ, Kokay IC, Anderson GM, Bunn SJ. Pregnancy-induced adaptation in the neuroendocrine control of prolactin secretion. J Neuroendocrinol. 2008;20:497\u2013507.","journal-title":"J Neuroendocrinol"},{"key":"9881_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00626026","volume":"258","author":"M Mazor","year":"1996","unstructured":"Mazor M, Hershkowitz R, Ghezzi F, Cohen J, Chaim W, Wiznitzer A, et al. Prolactin concentrations in preterm and term pregnancy and labour. Arch Gynecol Obstet. 1996;258:69\u201374.","journal-title":"Arch Gynecol Obstet"},{"key":"9881_CR44","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, et al. Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab. 2014;99:1712\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR45","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","volume":"343","author":"DM Hoffman","year":"1994","unstructured":"Hoffman DM, O\u2019Sullivan AJ, Ho KKY, Baxter RC. Diagnosis of growth-hormone deficiency in adults. Lancet. 1994;343:1064\u20138.","journal-title":"Lancet"},{"key":"9881_CR46","first-page":"2013","volume":"84","author":"A Hilding","year":"1999","unstructured":"Hilding A, Hall K, Wivall-Helleryd IL, S\u00e4\u00e4f M, Melin AL, Thor\u00e9n M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19\u201382 years, in relation to those in healthy subjects. J Clin Endocrinol Metab. 1999;84:2013\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR47","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1587\u2013609.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jpeds.2017.01.064","volume":"184","author":"LB Rolfsjord","year":"2017","unstructured":"Rolfsjord LB, Bakkeheim E, Berents TL, Alm J, Skjerven HO, Carlsen K-H, et al. Morning salivary cortisol in Young Children: reference values and the effects of Age, Sex, and Acute Bronchiolitis. J Pediatr. 2017;184:193\u2013e1983.","journal-title":"J Pediatr"},{"key":"9881_CR49","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.clinbiochem.2008.04.007","volume":"41","author":"J Kratzsch","year":"2008","unstructured":"Kratzsch J, Schubert G, Pulzer F, Pfaeffle R, Koerner A, Dietz A, et al. Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of life. Clin Biochem. 2008;41:1091\u20138.","journal-title":"Clin Biochem"},{"key":"9881_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11102-017-0792-z","volume":"20","author":"K Schilbach","year":"2017","unstructured":"Schilbach K, Strasburger CJ, Bidlingmaier M. Biochemical investigations in diagnosis and follow up of acromegaly. Pituitary. 2017;20:33\u201345.","journal-title":"Pituitary"},{"key":"9881_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-19-0139","volume":"181","author":"K Schilbach","year":"2019","unstructured":"Schilbach K, Gar C, Lechner A, Nicolay SS, Schwerdt L, Haenelt M, et al. Determinants of the growth hormone nadir during oral glucose tolerance test in adults. Eur J Endocrinol. 2019;181:55\u201367.","journal-title":"Eur J Endocrinol"},{"key":"9881_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-16-0668","volume":"176","author":"T Deutschbein","year":"2017","unstructured":"Deutschbein T, Bidlingmaier M, Schopohl J, Strasburger CJ, Petersenn S. Anthropometric factors have significant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifically measuring 22\u00a0kDa human growth hormone. Eur J Endocrinol. 2017;176:273\u201381.","journal-title":"Eur J Endocrinol"},{"key":"9881_CR53","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1210\/jc.2014-2830","volume":"99","author":"LE Dichtel","year":"2014","unstructured":"Dichtel LE, Yuen KCJ, Bredella MA, Gerweck AV, Russell BM, Riccio AD, et al. Overweight\/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab. 2014;99:4712\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1530\/EC-20-0491","volume":"10","author":"JM Garcia","year":"2021","unstructured":"Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, et al. Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. Endocr Connect. 2021;10:76\u201383.","journal-title":"Endocr Connect"},{"key":"9881_CR55","first-page":"950","volume":"76","author":"JP Miell","year":"1993","unstructured":"Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab. 1993;76:950\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"9881_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","volume":"66","author":"A Agha","year":"2007","unstructured":"Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, et al. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol. 2007;66:72\u20137.","journal-title":"Clin Endocrinol"},{"issue":"Suppl 1","key":"9881_CR57","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1530\/EJE-09-0319","volume":"161","author":"H Filipsson","year":"2009","unstructured":"Filipsson H, Johannsson G. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Eur J Endocrinol. 2009;161(Suppl 1):S85\u201395.","journal-title":"Eur J Endocrinol"},{"key":"9881_CR58","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1210\/endo-117-3-954","volume":"117","author":"A Garcia","year":"1985","unstructured":"Garcia A, Herbon L, Barkan A, Papavasiliou S, Marshall JC. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors. Endocrinology. 1985;117:954\u20139.","journal-title":"Endocrinology"},{"key":"9881_CR59","doi-asserted-by":"publisher","first-page":"e230342","DOI":"10.1530\/JOE-23-0342","volume":"261","author":"J Yang","year":"2024","unstructured":"Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol. 2024;261:e230342.","journal-title":"J Endocrinol"},{"key":"9881_CR60","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.3390\/ijms23158194","volume":"23","author":"VA Genchi","year":"2022","unstructured":"Genchi VA, Rossi E, Lauriola C, D\u2019Oria R, Palma G, Borrelli A, et al. Adipose tissue dysfunction and obesity-related male hypogonadism. Int J Mol Sci. 2022;23:8194.","journal-title":"Int J Mol Sci"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-024-09881-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T08:15:33Z","timestamp":1717834533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-024-09881-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["9881"],"URL":"https:\/\/doi.org\/10.1007\/s11154-024-09881-1","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"1 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}